Nanotechnology in Medical Devices Market

Executive Summary

Nanotechnology in Medical Devices Market was valued at US $3.27 billion in 2021 and is projected to grow at 9.00% CAGR over the forecast period to reach US $5.48 billion by 2027. Nanotechnology in Medical Devices Market represented US $0.52 billion opportunity over 2019-2021 and estimated to create US $2.21 billion opportunity in 2027 over 2021.

Nanotechnology in Medical Devices from Consainsights analyses the Nanotechnology in Medical Devices Market in the Life Sciences industry over the forecast period to 2027.

Nanotechnology in Medical Devices research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Nanotechnology in Medical Devices segmentation includes Product, Application and Geography.

Based on the Product, the Nanotechnology in Medical Devices analysis covers Active Implantable Devices, Biochips, Implantable Materials, Medical Textiles And Wound Dressings, Others.

In Product segment, Biochips segment has highest cagr growth of 7.96%.

Based on the Application, the Nanotechnology in Medical Devices analysis covers Therapeutic Applications, Research Applications, Diagnostic Applications.

In Application segment, Diagnostic Applications segment has highest cagr growth of 7.96%.

Based on the region, the Nanotechnology in Medical Devices analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include St. Jude Medical, Inc., Perkinelmer, Inc., Starkey Hearing Technologies, Stryker Corporation, Affymetrix, Inc., 3m Company, Smith & Nephew Plc, Mitsui Chemicals, Inc., Dentsply International, Aap Implantate Ag and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Product

Introduction

In 2021, Active Implantable Devices segment has the highest revenue of US $1.27 billion and is expected to grow at CAGR of 7.96% by 2027 Biochips segment has highest cagr growth of 7.96%.

Active Implantable Devices

Active Implantable Devices segment was valued at US $1.07 billion in 2019 and is projected to grow at 7.96% CAGR over the forecast period to reach US $2.13 billion by 2027. Active Implantable Devices segment represented US $0.20 billion opportunity over 2019-2021 and estimated to create US $0.86 billion opportunity in 2027 over 2021.

Biochips

Biochips segment was valued at US $0.62 billion in 2019 and is projected to grow at 7.96% CAGR over the forecast period to reach US $1.24 billion by 2027. Biochips segment represented US $0.12 billion opportunity over 2019-2021 and estimated to create US $0.50 billion opportunity in 2027 over 2021.

Implantable Materials

Implantable Materials segment was valued at US $0.48 billion in 2019 and is projected to grow at 7.96% CAGR over the forecast period to reach US $0.96 billion by 2027. Implantable Materials segment represented US $0.09 billion opportunity over 2019-2021 and estimated to create US $0.39 billion opportunity in 2027 over 2021.

Medical Textiles And Wound Dressings

Medical Textiles And Wound Dressings segment was valued at US $0.36 billion in 2019 and is projected to grow at 7.96% CAGR over the forecast period to reach US $0.72 billion by 2027. Medical Textiles And Wound Dressings segment represented US $0.07 billion opportunity over 2019-2021 and estimated to create US $0.29 billion opportunity in 2027 over 2021.

Others

Others segment was valued at US $0.22 billion in 2019 and is projected to grow at 7.96% CAGR over the forecast period to reach US $0.44 billion by 2027. Others segment represented US $0.04 billion opportunity over 2019-2021 and estimated to create US $0.18 billion opportunity in 2027 over 2021.

Application

Introduction

In 2021, Research Applications segment has the highest revenue of US $1.60 billion and is expected to grow at CAGR of 7.96% by 2027 Diagnostic Applications segment has highest cagr growth of 7.96%.

Therapeutic Applications

Therapeutic Applications segment was valued at US $1.27 billion in 2019 and is projected to grow at 7.96% CAGR over the forecast period to reach US $2.54 billion by 2027. Therapeutic Applications segment represented US $0.24 billion opportunity over 2019-2021 and estimated to create US $1.03 billion opportunity in 2027 over 2021.

Research Applications

Research Applications segment was valued at US $1.34 billion in 2019 and is projected to grow at 7.96% CAGR over the forecast period to reach US $2.68 billion by 2027. Research Applications segment represented US $0.25 billion opportunity over 2019-2021 and estimated to create US $1.08 billion opportunity in 2027 over 2021.

Diagnostic Applications

Diagnostic Applications segment was valued at US $0.13 billion in 2019 and is projected to grow at 7.96% CAGR over the forecast period to reach US $0.27 billion by 2027. Diagnostic Applications segment represented US $0.03 billion opportunity over 2019-2021 and estimated to create US $0.11 billion opportunity in 2027 over 2021.